Vice President, EU General Manager

<!-- --> <!-- --> <!-- --> <div> <!-- --> <div> <div> <p>Arrowhead Pharmaceuticals, Inc. (Nasdaq{{:}}  ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present…